Clinically Administered Doses of Pitavastatin and Rosuvastatin

In conclusion, a clinical dose of PTV was noted to directly inhibit cardiomyocyte hypertrophy and cardiac fibrosis, suggesting that lipophilic PTV can be a potential drug candidate against chronic heart failure.PMID:34853228 | DOI:10.1536/ihj.21-231

Source: International Heart Journal - December 2, 2021 Category: Cardiology Authors: Yasufumi Katanasaka Sae Hirano Yoichi Sunagawa Yusuke Miyazaki Hikaru Sato Masafumi Funamoto Kana Shimizu Satoshi Shimizu Nurmila Sari Koji Hasegawa Tatsuya Morimoto Source Type: research